How do cancer risks predicted from animal bioassays compare with the epidemiologic evidence? The case of ethylene dibromide

Irva Hertz-Picciotto, N. Gravitz, R. Neutra

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Cancer risks for ethylene dibromide (EDB) were estimated by fitting several linear nonthreshold additive models to data from a gavage bioassay. Risks predicted by these models were compared to the observed cancer mortality among a cohort of workers occupationally exposed to the same chemical. Models that accounted for the shortened latency period in the gavaged rats predicted upper bound risks that were within a factor of 3 of the observed cancer deaths. Data from an animal inhalation study of EDB also were compatible with the epidemiologic data. These findings contradict those of Ramsey et al. (1978), who reported that extrapolation from animal data produced highly exaggerated risk estimates for EDB-exposed workers. This paper explores the reasons for these discrepant findings.

Original languageEnglish (US)
Pages (from-to)205-214
Number of pages10
JournalRisk Analysis
Volume8
Issue number2
StatePublished - 1988
Externally publishedYes

Fingerprint

Ethylene Dibromide
Bioassay
Biological Assay
Ethylene
Animals
cancer
animal
evidence
Neoplasms
worker
Extrapolation
Inhalation
Rats
mortality
death
Mortality

ASJC Scopus subject areas

  • Safety, Risk, Reliability and Quality
  • Social Sciences (miscellaneous)

Cite this

How do cancer risks predicted from animal bioassays compare with the epidemiologic evidence? The case of ethylene dibromide. / Hertz-Picciotto, Irva; Gravitz, N.; Neutra, R.

In: Risk Analysis, Vol. 8, No. 2, 1988, p. 205-214.

Research output: Contribution to journalArticle

@article{35a1e06cb50b474abf4e8e6b6020d8d3,
title = "How do cancer risks predicted from animal bioassays compare with the epidemiologic evidence? The case of ethylene dibromide",
abstract = "Cancer risks for ethylene dibromide (EDB) were estimated by fitting several linear nonthreshold additive models to data from a gavage bioassay. Risks predicted by these models were compared to the observed cancer mortality among a cohort of workers occupationally exposed to the same chemical. Models that accounted for the shortened latency period in the gavaged rats predicted upper bound risks that were within a factor of 3 of the observed cancer deaths. Data from an animal inhalation study of EDB also were compatible with the epidemiologic data. These findings contradict those of Ramsey et al. (1978), who reported that extrapolation from animal data produced highly exaggerated risk estimates for EDB-exposed workers. This paper explores the reasons for these discrepant findings.",
author = "Irva Hertz-Picciotto and N. Gravitz and R. Neutra",
year = "1988",
language = "English (US)",
volume = "8",
pages = "205--214",
journal = "Risk Analysis",
issn = "0272-4332",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - How do cancer risks predicted from animal bioassays compare with the epidemiologic evidence? The case of ethylene dibromide

AU - Hertz-Picciotto, Irva

AU - Gravitz, N.

AU - Neutra, R.

PY - 1988

Y1 - 1988

N2 - Cancer risks for ethylene dibromide (EDB) were estimated by fitting several linear nonthreshold additive models to data from a gavage bioassay. Risks predicted by these models were compared to the observed cancer mortality among a cohort of workers occupationally exposed to the same chemical. Models that accounted for the shortened latency period in the gavaged rats predicted upper bound risks that were within a factor of 3 of the observed cancer deaths. Data from an animal inhalation study of EDB also were compatible with the epidemiologic data. These findings contradict those of Ramsey et al. (1978), who reported that extrapolation from animal data produced highly exaggerated risk estimates for EDB-exposed workers. This paper explores the reasons for these discrepant findings.

AB - Cancer risks for ethylene dibromide (EDB) were estimated by fitting several linear nonthreshold additive models to data from a gavage bioassay. Risks predicted by these models were compared to the observed cancer mortality among a cohort of workers occupationally exposed to the same chemical. Models that accounted for the shortened latency period in the gavaged rats predicted upper bound risks that were within a factor of 3 of the observed cancer deaths. Data from an animal inhalation study of EDB also were compatible with the epidemiologic data. These findings contradict those of Ramsey et al. (1978), who reported that extrapolation from animal data produced highly exaggerated risk estimates for EDB-exposed workers. This paper explores the reasons for these discrepant findings.

UR - http://www.scopus.com/inward/record.url?scp=0023677905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023677905&partnerID=8YFLogxK

M3 - Article

C2 - 3045903

AN - SCOPUS:0023677905

VL - 8

SP - 205

EP - 214

JO - Risk Analysis

JF - Risk Analysis

SN - 0272-4332

IS - 2

ER -